EBV genome carrying B lymphocytes that express the nuclear protein EBNA-2 but not LMP-1
Authors:
Open Access
- 1 February 2013
- journal article
- Published by Taylor & Francis in OncoImmunology
- Vol. 2 (2) , e23035
Abstract
The potentially oncogenic Epstein-Barr virus (EBV) is carried by almost all humans in a well equilibrated coexistence. The phenotype of the cells that carry EBV genomes is determined by virally-encoded and cellular proteins. B lymphocyte is the main target of the virus and latent infection of this cell induces proliferation. Nine virus-encoded genes participate in the “growth program” that is expressed in a narrow differentiation window of the B cell. Such cells have the potential to develop malignant proliferations. However, several control mechanism eliminate this danger and the general chronic virus carrier state is most often asymptomatic. One mechanism exploits the normal regulation in the immune system, the T cell mediated modulation of the B cell differentiation state. Another is based on cognate recognition and elimination of the infected cells. The expression of EBV encoded genes in B lymphocytes can be also “restricted,” they do not express all components of the viral growth program. Here, we discuss a rare viral expression in B cells that has not been connected with malignant transformation yet.Keywords
This publication has 58 references indexed in Scilit:
- Soluble factors produced by activated CD4+T cells modulate EBV latencyProceedings of the National Academy of Sciences, 2012
- Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infectionOncoImmunology, 2012
- A New Model of Epstein-Barr Virus Infection Reveals an Important Role for Early Lytic Viral Protein Expression in the Development of LymphomasJournal of Virology, 2011
- To the genesis of Burkitt lymphoma: Regulation of apoptosis by EBNA-1 and SAP may determine the fate of Ig-myc translocation carrying B lymphocytesSeminars in Cancer Biology, 2009
- IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoterProceedings of the National Academy of Sciences, 2009
- How does Epstein–Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?Seminars in Cancer Biology, 2009
- The curious case of the tumour virus: 50 years of Burkitt's lymphomaNature Reviews Microbiology, 2008
- CD34+ Cord Blood Cell-Transplanted Rag2−/− γc−/− Mice as a Model for Epstein-Barr Virus InfectionThe American Journal of Pathology, 2008
- Infectious Mononucleosis, Childhood Social Environment, and Risk of Hodgkin LymphomaCancer Research, 2007
- Three restricted forms of Epstein–Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cellsProceedings of the National Academy of Sciences, 2006